Cells | Free Full-Text | Trends and Challenges in Tumor Anti-Angiogenic Therapies | HTML
Anti-VEGF Molecular Targeted Therapies in Common Solid Malignancies: Comprehensive Update for Radiologists | RadioGraphics
Tumour vasculature targeted anti-cancer therapy
Frontiers | Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities | Immunology
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma | Immunotherapy
VEGF-targeted therapy: mechanisms of anti-tumour activity | Semantic Scholar
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era - European Urology
Frontiers | Targeting VEGF/VEGFR to Modulate Antitumor Immunity | Immunology
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy | Journal of Hematology & Oncology | Full Text
Mechanisms of resistance to anti-angiogenic treatments
Molecular targeted therapies for breast cancer treatment | Breast Cancer Research | Full Text
Frontiers | Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies | Cell and Developmental Biology
VEGF-targeted therapy: mechanisms of anti-tumour activity | Nature Reviews Cancer
Tumour vasculature targeted anti-cancer therapy
Mechanism of action of anti-VEGF agents in colorectal cancer (adapted... | Download Scientific Diagram
Enhancing anti-tumour efficacy with immunotherapy combinations - The Lancet
Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
VEGF-targeted therapy: mechanisms of anti-tumour activity | Nature Reviews Cancer
Frontiers | Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma | Pharmacology
Targeted therapy - Wikipedia
Future options of anti-angiogenic cancer therapy | Cancer Communications | Full Text
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma | CNS Oncology
VEGF-targeted therapy: mechanisms of anti-tumour activity | Nature Reviews Cancer
Avastin® (bevacizumab) Proposed MOA | MCRC Treatment
